tiprankstipranks

New Portfolio - New Portfolio

Alexej Crimotat

New Portfolio
Individual Investor
Ranked #433,562 out of 775,923 TipRanks' Investors
Success Rate
33%
18 out of 55
profitable transactions
Average Return
0.72%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 6.54%
6-Month Return▲ 26.35%
12-Month Return▲ 40.88%
YTD Return▲ 39.32%
Total Return▲ 93.09%

Best Trade

Opened at
Closed at-
Gain▲ 357.18%

Bio

Only for the Brave

Performance

43.22%0-43.22%
▲ 11.46%
▲ 5.06%
▲ 8.39%
May 2024
▼ 2.25%
▲ 3.53%
▼ 7.32%
Jun 2024
▲ 25.71%
▲ 1.21%
▲ 3.21%
Jul 2024
▼ 4.22%
▲ 2.34%
▼ 1.04%
Aug 2024
▲ 7.82%
▲ 2.10%
▲ 2.62%
Sep 2024
▲ 5.38%
▼ 0.89%
▲ 3.41%
Oct 2024
▲ 43.22%
▲ 5.96%
▲ 12.93%
Nov 2024
▲ 3.34%
▼ 1.56%
▲ 0.81%
Dec 2024
TipRanks AverageS&P 500Investor Portfolio
▲ 11.46%▲ 5.06%▲ 8.39%
▼ 2.25%▲ 3.53%▼ 7.32%
▲ 25.71%▲ 1.21%▲ 3.21%
▼ 4.22%▲ 2.34%▼ 1.04%
▲ 7.82%▲ 2.10%▲ 2.62%
▲ 5.38%▼ 0.89%▲ 3.41%
▲ 43.22%▲ 5.96%▲ 12.93%
▲ 3.34%▼ 1.56%▲ 0.81%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
COMPASS Pathways
3.99%
▼ 29.34%
2
Buy
Dec 19, 2024
Coinbase Global
14.97%
▲ 18.55%
3
Buy
Dec 19, 2024
Microstrategy
15.52%
▼ 0.06%
2
Buy
Dec 19, 2024
Occidental Petroleum
5.09%
▲ 3.57%
1
Open
Dec 19, 2024
Broadcom
4.88%
▼ 4.69%
1
Open
Dec 17, 2024
Intellia Therapeutics
2.65%
▼ 5.21%
1
Open
Dec 17, 2024
Abivax SA
0%
▲ 2.26%
1
Open
Dec 17, 2024
MongoDB
5.24%
▲ 2.61%
3
Close
Dec 11, 2024
Alphabet Class A
6.11%
▲ 0.42%
1
Open
Dec 11, 2024
Roku
1.72%
▲ 26.08%
2
Buy
Dec 08, 2024
ARM Holdings PLC ADR
2.82%
▲ 56.08%
2
Buy
Dec 08, 2024
Avidity Biosciences
3.4%
▲ 171.77%
2
Buy
Dec 08, 2024
Metagenomi, Inc.
4.32%
▼ 34.29%
2
Buy
Dec 08, 2024
Salesforce
3.55%
▲ 33.84%
2
Buy
Dec 08, 2024
Nike
1.63%
▲ 5.26%
2
Buy
Dec 08, 2024
The Estée Lauder Companies
3.19%
▼ 16.89%
2
Buy
Dec 08, 2024
Lululemon Athletica
4.07%
▲ 15.34%
2
Buy
Dec 08, 2024
e.l.f. Beauty
1.34%
▼ 17.58%
2
Buy
Dec 08, 2024
Nvidia
5.72%
▲ 10.20%
2
Buy
Dec 08, 2024
Iqiyi
2.2%
▼ 17.50%
2
Buy
Dec 08, 2024